Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
32
Top-10 weight
39.90%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
29
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
680.9
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | MODERNA INC | — | 2,351,289 | $119.45M | 5.26% |
| 2 | UNITED THERAPEUTICS CORP DEL | — | 166,849 | $98.94M | 4.36% |
| 3 | ALKERMES PLC | — | 2,719,064 | $96.15M | 4.24% |
| 4 | GILEAD SCIENCES INC | — | 665,992 | $92.82M | 4.09% |
| 5 | AXSOME THERAPEUTICS INC | — | 521,878 | $88.21M | 3.89% |
| 6 | AMGEN INC | — | 247,283 | $87.01M | 3.83% |
| 7 | CORCEPT THERAPEUTICS INC | — | 2,150,626 | $86.69M | 3.82% |
| 8 | KRYSTAL BIOTECH INC | — | 308,504 | $79.69M | 3.51% |
| 9 | BIOGEN INC | — | 429,853 | $78.80M | 3.47% |
| 10 | EXELIXIS INC | — | 1,831,270 | $78.54M | 3.46% |
| 11 | NEUROCRINE BIOSCIENCES INC | — | 593,926 | $78.24M | 3.45% |
| 12 | REGENERON PHARMACEUTICALS INC | — | 101,249 | $78.23M | 3.45% |
| 13 | VERTEX PHARMACEUTICALS INC | — | 173,834 | $77.62M | 3.42% |
| 14 | BIOMARIN PHARMACEUTICAL INC | — | 1,368,040 | $77.28M | 3.40% |
| 15 | ARGENX SE SPONSORED ADR | — | 102,325 | $74.72M | 3.29% |
| 16 | SAREPTA THERAPEUTICS INC | — | 3,384,344 | $73.64M | 3.24% |
| 17 | HALOZYME THERAPEUTICS INC | — | 1,112,843 | $71.92M | 3.17% |
| 18 | BIONTECH SE ADR | — | 807,711 | $71.79M | 3.16% |
| 19 | INCYTE CORP | — | 754,631 | $71.03M | 3.13% |
| 20 | BEONE MEDICINES LTD ADR | — | 238,672 | $70.88M | 3.12% |
| 21 | ILLUMINA INC | — | 571,731 | $70.47M | 3.10% |
| 22 | NATERA INC | — | 344,198 | $68.84M | 3.03% |
| 23 | ACADIA PHARMACEUTICALS INC | — | 3,011,495 | $67.04M | 2.95% |
| 24 | ALNYLAM PHARMACEUTICALS INC | — | 202,492 | $67.00M | 2.95% |
| 25 | BIO-TECHNE CORP | — | 1,227,575 | $64.15M | 2.83% |
| 26 | GENMAB A/S -SP ADR DEPOSITARY RECEIPT | GMAB | 2,354,019 | $63.16M | 2.78% |
| 27 | VERACYTE INC | — | 1,918,341 | $61.79M | 2.72% |
| 28 | REPLIGEN CORP | — | 483,433 | $56.96M | 2.51% |
| 29 | BRUKER CORP | — | 1,480,923 | $53.49M | 2.36% |
| 30 | NEOGENOMICS INC | — | 6,128,278 | $45.47M | 2.00% |
| 31 | DREY-GVT CSH-I | MISXX | 1,413,994 | $1.41M | 0.06% |
| 32 | DAIWA CAPITAL MARKETS AMERICA INC | — | 188,488 | $188.49K | 0.01% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.